Abstract
Background Left main (LM) percutaneous coronary intervention (PCI) with routine intracoronary imaging guidance is recommended; however, its real-world effectiveness remains unclear. This study aimed to investigate the outcomes in a Japanese National Hospital Organization cohort in which routine imaging guidance was adopted.
Methods Of the 806 consecutive patients undergoing drug-eluting stent implantation for de novo unprotected LM lesions across 19 hospitals, 743 were analyzed after excluding 63 owing to criteria mismatch or incomplete follow-up. The primary endpoint was 1-year major adverse cardiovascular and cerebrovascular events (MACCE), comprising all-cause death, cerebrovascular disorder, clinical-driven revascularization, and myocardial infarction.
Results The cohort exhibited increased prevalences of diabetes mellitus, prior myocardial infarction, and prior revascularization. Acute coronary syndrome was present in 31.2% of the patients, with 39.3% classified as Canadian Cardiovascular Society functional angina (CCS) class ≥III. LM bifurcation lesions were observed in 78.0% of the patients, with two-stent implantation in 8.8% of the patients. MACCE occurred in 17.5% of the patients, with target lesion revascularization and cardiac death rates of 2.0% and 3.4%, respectively. Independent risk factors for MACCE included CCS class ≥III (hazard ratio [HR], 2.07), mechanical cardiac support device use (HR, 2.17), two-stent implantation (HR, 2.49), 10% increase in left ventricular ejection fraction (HR, 0.72), and radial access (HR, 0.62).
Conclusion Routine imaging-guided LM-PCI is associated with a lower incidence of target lesion revascularization and cardiac death. However, severe left ventricular dysfunction and multiple-vessel involvement are associated with higher mortality and revascularization risks, requiring comprehensive management beyond imaging-guided PCI.
What is new?
This study clarifies the clinical outcomes of left main coronary intervention guided by routine intracoronary imaging, revealing a low frequency of target lesion revascularization and cardiac death.
Despite the favorable local efficacy of imaging guidance, patients with severe left ventricular dysfunction and multiple-vessel involvement still face elevated risks of mortality and revascularization.
What are the clinical implications?
Intracoronary imaging guidance in the left main coronary artery is crucial for optimizing intervention treatments and enhancing local efficacy at the treated sites.
Despite these improvements, the high mortality rate associated with serious myocardial damage from left main coronary artery obstruction underscores the importance of careful consideration in such cases.
Coronary artery disease involving the left main and multiple vessels carries an elevated risk of additional revascularizations beyond the target lesion, emphasizing the need for comprehensive management strategies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study was registered in the University Hospital Medical Information Network (ID: UMIN 000037332).
Funding Statement
The study is supported by a Grant-in-Aid for Clinical Research from the National Hospital Organization in Japan.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Institutional Review Board of the Japanese National Hospital Organization and each attending hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, [Yoshinobu Murasato], upon reasonable request.
Non-standard Abbreviations and Acronyms
- CABG
- coronary artery bypass graft
- CCS
- Canadian Cardiovascular Society functional angina classification
- CI
- confidence interval
- DES
- drug-eluting stent
- HR
- hazard ratio
- IVUS
- intravascular ultrasound
- KBI
- kissing balloon inflation
- LAD
- left anterior descending artery
- LCX
- left circumflex artery
- LM
- left main
- LM-JANHO
- left main coronary intervention in a cohort of Japanese National Hospital Organization
- MACCE
- major adverse cardiovascular and cerebrovascular events
- MV
- main vessel
- OFDI
- optical frequency dependent imaging
- OCT
- optical coherence tomography
- OR
- odds ratio
- PCI
- percutaneous coronary intervention
- POT
- proximal optimal technique
- SB
- side branch
- SYNTAX
- Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery
- TLR
- target lesion revascularization
- TVR
- target vessel revascularization
